Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The FDA stated it lacks sufficient information to know whether the drug would cause harm when administered to humans
The sequence structure allows the molecule to remain intact in gastric environments for extended periods, with studies reporting stability in human gastric juice for more than 24 hours [1]
Research models by Bhm et al
Retatrutide (CAS 2381089-83-2) is a triple-agonist peptide that engages three receptors simultaneously the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor making it one of the most-studied multi-receptor metabolic peptides currently in the research literature
US$ 20.40
US$ 25.14
US$ 23.79
US$ 21.62
